London, United Kingdom, March 2025 – Adwait Kashalkar has been appointed as Director, Strategic Workforce Planning and Acquisition Lead at Astellas Pharma. In this role, he will focus on enhancing workforce planning capabilities, optimizing talent strategies, and driving impactful HR initiatives to strengthen the organization’s global workforce framework.
Kashalkar brings nearly six years of experience from Mastercard, where he most recently served as People Analytics and Programme Management Lead, AP Region & Lead, Global Workforce Data Operations. In this role, he led key HR and business projects across Asia Pacific, driving workforce insights, M&A coordination, talent strategy, and performance calibration. He played a pivotal role in developing workforce forecasts, optimizing HR processes, and providing consulting to senior stakeholders on complex workforce initiatives.
Prior to Mastercard, Kashalkar was with PwC Singapore as Saratoga APAC CoE Lead, leading human capital measurement and benchmarking projects across Southeast Asia. He specialized in M&A advisory, HR transformation, and workforce productivity, helping organizations enhance their HR frameworks and strategic planning. Before that, he spent several years with PwC in Malaysia and India, working as Associate Director and Principal Consultant in People & Change, delivering HR strategy, organization design, and workforce analytics solutions.
Kashalkar holds an MBA in Human Resources from XLRI Jamshedpur, bringing a strong academic foundation to his extensive industry expertise in HR analytics, strategic workforce planning, and organizational transformation.
About Astellas Pharma
Astellas Pharma is a global pharmaceutical company dedicated to developing innovative drugs that address high unmet medical needs. The company focuses on cutting-edge science to improve patient outcomes, providing life-changing treatments across multiple therapeutic areas. Astellas operates in over 70 countries, maintaining the highest ethical standards and compliance with global healthcare regulations. The company strives to enhance quality across drug discovery, development, production, and commercialization, ensuring meaningful contributions to the global healthcare landscape.
Read Also : Entering 2025, TA Leaders’ Success Built on More than Just Hiring, Says The Josh Bersin Company
People Analytics Teams Still Struggle to Deliver Business Impact, Warns The Josh Bersin Company
ESG and Women’s Leadership: Driving Sustainability and Inclusion
Learning and Development Trends for 2025: Shaping the Future of Workplace Learning
